World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03134612
Date of registration: 24/04/2017
Prospective Registration: No
Primary sponsor: Indonesia University
Public title: Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection
Scientific title: Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection
Date of first enrolment: July 2016
Target sample size: 104
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03134612
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Double (Participant, Care Provider).  
Phase:  Phase 2
Countries of recruitment
Indonesia
Contacts
Name:     Aries Perdana, Consultant
Address: 
Telephone:
Email:
Affiliation:  Indonesia University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Subjects aged 18-65 years old

- Subjects were planned to undergo general anesthesia with propofol

- Subjects with Body Mass Index (BMI) 18-35 kg/m2

- Subjects with American Society of Anesthesiologists (ASA) physical status of I-II

- Subjects with signed informed consent.

Exclusion Criteria:

- Subjects with allergies to propofol, lidocain, ondansetron

- Subjects with massive cardiac disorder

- Subjects with cardiac rhythm disorder with or without treatment

- Subjects with unstable hemodynamic

- Subjects with contraindication to propofol, lidocain, ondansetron

- Subjects with intubation and ventilation difficulty

- Subjects with decreased consciousness, seizure history or head injury

- Subjects with analgesic treatment history

- Subjects with pregnancy.

Drop out criteria:

- Subjects with allergic reactions induced by propofol, lidocain, ondansetron

- Uncooperative subjects

- Subjects in emergency

- Subjects with difficult vein access in the dorsum manus

- Subjects with infection and/or inflammation in the planned intravenous cannulation
location.



Age minimum: 18 Years
Age maximum: 65 Years
Gender: All
Health Condition(s) or Problem(s) studied
General Anesthesia With Propofol
Intervention(s)
Drug: Ondansetron 8 mg
Drug: Lidocain 40 mg
Primary Outcome(s)
The Degree of pain due to Propofol Injection [Time Frame: Day 1]
Secondary Outcome(s)
Secondary ID(s)
IndonesiaUAnes005
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history